Vietnam General Surgery Devices Market Size, Share & Forecast, By Product Type, Application & End User, 2026–2031
Vietnam
July 2026

Vietnam General Surgery Devices Market Size, Share & Forecast, By Product Type, Application & End User, 2026–2031

2031

Vietnam General Surgery Devices Market expected to reach $352.9 million by 2031, growing at 8.90% CAGR driven by higher surgical demands and facility expansion.

Report Details

Base Year

2025

Region

Vietnam

Pages

99

Author

Ken Research

Product Code

KR-RPT-V02-01543

CHAPTER 1 - MARKET SUMMARY

Market Overview

The Vietnam General Surgery Devices Market operates through multinational manufacturers, authorized importers, local distributors and hospital procurement departments. Demand is anchored by a national population of 102.3 million in 2025 and a procedure base spanning abdominal, gastrointestinal, colorectal, hernia and endocrine surgery. Higher chronic disease incidence is increasing demand for staplers, energy systems, access devices and closure products.

Southern Vietnam is the principal commercial hub because Ho Chi Minh City combines tertiary hospitals, private healthcare chains, specialist training centers, distributors and import infrastructure. Vietnam had 384 private hospitals representing approximately 24% of hospitals in 2024, although these facilities held only 5.8% of national bed capacity. This creates concentrated demand for premium devices in high-throughput urban institutions.

Market Value

USD 211.6 million

2025

Dominant Region

Southern Vietnam

2025

Dominant Segment

Surgical Staplers and Closure Devices

fastest growing, 2026-2031

Total Number of Players

125

Future Outlook

The Vietnam General Surgery Devices Market is projected to increase from USD 211.6 million in 2025 to USD 352.9 million by 2031. The market expanded at a historical CAGR of 7.32% during 2020-2025, despite pandemic-related surgical disruption in 2020 and 2021. Forecast growth of 8.90% reflects higher inpatient utilization, expansion of private surgical facilities, adoption of laparoscopic techniques and rising use of disposable access, energy and wound-closure products. Market volume is projected to rise from 6.41 million procedure-equivalent device units in 2025 to 9.56 million units by 2031, representing a 6.89% volume CAGR.

Value growth is expected to remain above volume growth as hospitals transition toward advanced bipolar energy devices, powered staplers, integrated smoke evacuation, fluorescence-enabled visualization and procedure-specific consumable kits. The minimally invasive share of general surgery procedures is modeled to increase from 36% in 2025 to 54% in 2031, while single-use products rise from 63% to 75% of standardized device volume. Southern Vietnam will retain the largest revenue pool, although provincial hospitals in Northern and Central Vietnam will generate faster replacement demand as procurement normalizes and surgeon training expands beyond major tertiary institutions.

8.90%

Forecast CAGR

$352.9 Mn

2030 Projection

Base Year

2025

Historical Period

2020-2025

Forecast Period

2026-2031

Historical CAGR

7.32%

CHAPTER 2 - SCOPE OF REPORT

Scope of the Market

Click to Explore Interactive Mind Map

CHAPTER 3 - Key Stakeholders

Key Target Audience

Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.

Investors

CAGR, procedure volume, consolidation, regulatory risk, margin pools

Corporates

portfolio mix, tender access, pricing, distributor productivity, localization

Government

import dependence, device access, compliance, procurement efficiency, localization

Operators

procedure costs, utilization, sterilization, training, inventory availability

Financial institutions

distributor finance, hospital capex, receivables, demand stability, covenants

What You'll Gain

  • Market sizing and trajectory
  • Procedure demand indicators
  • Policy and compliance mapping
  • Segment structure and levers
  • Competitive landscape shortlist
  • CEO-grade risk priorities

80+

Pages of insights

CHAPTER 4 - Market Size & Growth

Market Size, Growth Forecast and Trends

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.

Historical & Projected Market Size ($ Million)

Year-over-Year Growth Rate (%)

Market Value vs Volume Growth (%)

Historical Market Performance, 2020-2025

The market recorded its lowest annual growth of 1.8% in 2021 as elective procedures, capital budgets and public tenders remained disrupted. Growth accelerated to 9.5% in 2022, supported by deferred procedure completion, distributor restocking and reopening of specialist surgical departments. The market then expanded by 9.1% in 2023 and 7.5% in 2024. Demand concentration remained highest in tertiary hospitals, while the single-use product mix increased from 54% of standardized volume in 2020 to 63% in 2025. Historical value CAGR reached 7.32%, compared with approximately 5.95% volume growth.

Forecast Market Outlook, 2026-2031

Forecast value is projected to rise from USD 230.4 million in 2026 to USD 352.9 million by 2031 at an 8.90% CAGR from the 2025 base. Value growth will exceed the 6.89% volume CAGR because hospitals are expected to adopt powered staplers, advanced bipolar devices, improved visualization platforms and higher-value disposable kits. The minimally invasive procedure share is modeled to increase by 18 percentage points between 2025 and 2031. Provincial hospital upgrades, private capital deployment and surgeon training will broaden demand beyond Hanoi and Ho Chi Minh City while supporting a higher blended average selling price.

CHAPTER 5 - Market Data

Market Breakdown

The Vietnam General Surgery Devices Market combines recurring disposable demand with replacement purchases for reusable instruments, visualization systems and energy platforms. Its trajectory is strategically relevant because supplier economics increasingly depend on procedure utilization, single-use penetration and the migration of hospitals toward minimally invasive surgery.

Market Breakdown

Historical Data (2020-2024) • Base Data (2025) • Forecast Data (2026F-2031F)

Year
Market Size (USD Mn)
YoY Growth (%)
Procedure-Equivalent Device Volume (Mn Units)
Single-Use Device Mix (%)
Minimally Invasive Procedure Share (%)
Period
2020$148.6 Mn+-4.8054%
$#%
Forecast
2021$151.3 Mn+1.8%4.9155%
$#%
Forecast
2022$165.7 Mn+9.5%5.2457%
$#%
Forecast
2023$180.8 Mn+9.1%5.6159%
$#%
Forecast
2024$194.4 Mn+7.5%6.0061%
$#%
Forecast
2025$211.6 Mn+8.8%6.4163%
$#%
Forecast
2026F$230.4 Mn+8.9%6.8465%
$#%
Forecast
2027F$250.9 Mn+8.9%7.3067%
$#%
Forecast
2028F$273.3 Mn+8.9%7.8069%
$#%
Forecast
2029F$297.6 Mn+8.9%8.3471%
$#%
Forecast
2030F$324.1 Mn+8.9%8.9373%
$#%
Forecast
2031F$352.9 Mn+8.9%9.5675%
$#%
Forecast

Procedure-Equivalent Device Volume

6.41 million units, 2025, Vietnam. Volume indicates the recurring addressable pool for instruments, access products and closure devices. Vietnam recorded more than 17 million inpatient treatments during 2024, supporting a substantial procedure funnel.

Single-Use Device Mix

63%, 2025, Vietnam. A higher disposable mix supports recurring revenue and reduces sterilization workflow requirements, but increases exposure to imported consumables. More than 90% of Vietnam's broader medical equipment and supply demand is import-dependent.

Minimally Invasive Procedure Share

36%, 2025, Vietnam. Greater laparoscopy penetration expands demand for trocars, insufflation, energy and visualization products. Olympus Medical Systems Vietnam and University Medical Center Ho Chi Minh City established a 2025 collaboration focused on advanced endoscopic and laparoscopic training.

CHAPTER 6 - Segmentation

Market Segmentation Framework

Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.

No of Segments

7

Dominant Segment

Product Type

Fastest Growing Segment

Technology

Product Type

Handheld Surgical Instruments
$%
Electrosurgical Devices
$%
Surgical Staplers and Closure Devices
$%
Laparoscopic Access and Visualization Devices
$%

Care Setting

Public Tertiary Hospitals
$%
Provincial and District Hospitals
$%
Private General Hospitals
$%
Ambulatory Surgery Centers
$%

End User

General Surgeons
$%
Gastrointestinal Surgeons
$%
Hepatobiliary Surgeons
$%
Colorectal Surgeons
$%

Application

Abdominal Surgery
$%
Gastrointestinal Surgery
$%
Hernia Repair
$%
Breast and Endocrine Surgery
$%

Sales Channel

Public Hospital Tenders
$%
Direct Institutional Sales
$%
Authorized Medical Distributors
$%
Private Hospital Framework Contracts
$%

Technology

Conventional Open Surgery
$%
Laparoscopic Surgery
$%
Advanced Energy Surgery
$%
Robotic-Assisted Surgery
$%

Geography

Southern Vietnam
$%
Northern Vietnam
$%
Central Vietnam
$%
Mekong Delta
$%

Key Segmentation Takeaways

Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.

Product Type

Product economics determine procurement frequency, gross margin, clinical training requirements and supplier lock-in. Handheld instruments provide the broadest installed base, while surgical staplers and closure devices generate stronger recurring revenue through procedure-specific cartridges, reloads and consumables. Suppliers with integrated access, energy and closure portfolios can compete for bundled hospital tenders and standardize surgeon workflows across multiple procedure categories.

Technology

Technology is the fastest-growing dimension as hospitals migrate from conventional open procedures toward laparoscopy, advanced energy and selected robotic-assisted workflows. Advanced bipolar sealing is expected to lead near-term growth because it improves procedural efficiency without requiring the capital intensity of robotics. High-definition visualization, smoke management and integrated insufflation will increasingly influence tender specifications and clinical preference in tertiary hospitals.

CHAPTER 7 - Regional Analysis

Regional Analysis

Vietnam ranks as a mid-sized but comparatively fast-growing general surgery device market among selected Southeast Asian peers. Its 102.3 million population, expanding insurance coverage and import-led technology base support stronger growth than several mature neighboring markets, although Indonesia and Thailand retain larger absolute revenue pools.

Focus Country Ranking

3rd

Focus Country Market Size

USD 211.6 Mn, 2025

Vietnam CAGR (2026-2031)

8.9%

Regional Analysis (Current Year)

Regional Analysis Comparison

MetricIndonesiaThailandVietnamMalaysiaPhilippines
Market Size, 2025 (USD Mn)315.0390.0211.6170.094.0
CAGR, 2026-2031 (%)9.4%7.1%8.9%7.6%8.2%
Annual Inpatient Admissions (Mn)37.07.017.04.012.0
Medical Device Import Dependence (%)88%70%90%65%95%

Market Position

Vietnam ranks third among the five selected peer countries with a modeled 2025 market size of USD 211.6 million, supported by 17 million annual inpatient treatments and expanding tertiary surgical capacity.

Growth Advantage

Vietnam's projected 8.9% CAGR exceeds Thailand's modeled 7.1% and Malaysia's 7.6%, positioning the country as a growth challenger driven by hospital investment, insurance expansion and minimally invasive surgery adoption.

Competitive Strengths

Vietnam combines 102.3 million residents, 94.2% health insurance coverage and 1,645 hospitals, creating a broad procedure funnel while allowing suppliers to concentrate premium portfolios in major urban surgical centers.

CHAPTER 8 - INDUSTRY ANALYSIS

Growth Drivers, Market Challenges, Market Opportunities, Growth Driver Framework, Volume Projection, Value Projection & Scenario Projections

Comprehensive analysis of key factors shaping the Vietnam General Surgery Devices Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and healthcare provider segments.

Growth Drivers

Expanding Hospital Utilization and Insurance Coverage

  • Health insurance covered 94.2% of the population (2024, Vietnam), reducing access barriers and supporting hospital-based diagnosis, admission and reimbursable surgery volumes.
  • The healthcare network included 1,645 hospitals (2024, Vietnam), creating a large installed base requiring instrument replacement, sterilization support and recurring disposable supply.
  • Bed capacity reached 34 beds per 10,000 people (2024, Vietnam), expanding the infrastructure available for inpatient surgery and post-operative recovery.

Shift Toward Minimally Invasive Surgery

  • The minimally invasive surgical device category was estimated at USD 40.12 million (2024, Vietnam), supporting demand for access ports, graspers, energy devices and visualization systems.
  • Olympus and a major university medical center established a 2025 laparoscopic training collaboration (Vietnam), supporting surgeon capability and utilization of advanced endoscopic platforms.
  • Stomach and colorectal cancers remain among Vietnam's most prevalent cancers, expanding the addressable pool for gastrointestinal surgical devices (2025, Vietnam).

Private Healthcare Capital and Distribution Consolidation

  • Private facilities represented approximately 24% of hospitals (2024, Vietnam), giving manufacturers a focused route for introducing advanced energy, stapling and visualization systems.
  • Dawn Medical Technologies acquired control of Pinnacle in 2026 (Vietnam), signaling investor interest in distributor scale, regulatory expertise and hospital relationships.
  • Vietnam's broader medical device market is forecast to reach USD 2.84 billion by 2029 (Vietnam), supporting portfolio expansion and distributor investment.

Market Challenges

High Import Dependence and Currency Exposure

  • Imported brands must absorb international freight, inventory financing and distributor margins, which raises the landed cost of advanced surgical systems (2025, Vietnam).
  • Foreign exchange movement affects public tender competitiveness because suppliers often commit fixed bid prices while sourcing devices in USD or EUR (2025, Vietnam).
  • Out-of-pocket spending represented approximately 40% of current health expenditure (2022, Vietnam), increasing price sensitivity where insurance coverage or hospital budgets do not fully fund premium devices.

Registration, Tender and Price-Declaration Complexity

  • Decree No. 98/2021 requires product classification, market authorization, traceability and safety accountability, raising the cost of maintaining multi-SKU portfolios (2022 onward, Vietnam).
  • Medical device prices may require declaration before market placement, limiting pricing flexibility when freight, exchange rates or supplier transfer prices change during contract periods (2025, Vietnam).
  • A proposed centralized procurement list covered 20 medical devices and diagnostic consumables (2025, Vietnam), signaling greater standardization and price scrutiny in public purchasing.

Uneven Capacity and Specialist Availability

  • Vietnam's overall bed occupancy rate reached 95.5% in 2022, constraining operating-room scheduling, recovery capacity and elective procedure throughput.
  • Provincial hospital occupancy reached 129% in 2022 (Vietnam), indicating overcrowding and limited ability to introduce workflow-intensive surgical technology without supporting infrastructure.
  • Advanced device utilization depends on surgeon training, biomedical engineering support and sterilization capability, creating slower adoption across district-level facilities (2025, Vietnam).

Market Opportunities

Procedure-Specific Single-Use Device Portfolios

  • Bundled trocar, energy, suction and closure kits can convert fragmented purchasing into procedure-based contracts, improving forecastability for manufacturers and distributors (2026-2031, Vietnam).
  • Public and private hospitals benefit from standardized kits through simpler inventory control, lower instrument reprocessing requirements and clearer cost per procedure (2025, Vietnam).
  • Adoption requires suppliers to demonstrate infection-control value, reliable replenishment and acceptable tender economics across a network of 1,645 hospitals (2024, Vietnam).

Local Assembly, Sterile Packaging and Refurbishment

  • Local sterile packaging and final assembly can reduce freight intensity, shorten replenishment cycles and create a cost advantage in high-volume consumables (2026-2031, Vietnam).
  • Domestic manufacturers, contract packagers and hospital service companies can capture value from reusable instrument maintenance, calibration and traceability services (2025, Vietnam).
  • Investment requires ISO-aligned quality systems, validated sterilization, product registration capability and procurement recognition for locally processed devices (2026-2031, Vietnam).

Training-Led Minimally Invasive Surgery Ecosystems

  • Manufacturers can monetize equipment, instruments, disposables and service contracts by linking technology placement with structured surgeon training programs (2026-2031, Vietnam).
  • Tertiary hospitals and teaching centers benefit through standardized techniques, broader specialist capability and stronger referral positioning for complex surgical cases (2025, Vietnam).
  • Opportunity realization requires proctoring, biomedical support, maintenance coverage and measurable procedure economics beyond Hanoi and Ho Chi Minh City (2026-2031, Vietnam).

CHAPTER 9 - Competitive Landscape

Competitive Landscape Overview

The market is moderately concentrated among global surgery brands and specialized distributors. Clinical preference, regulatory authorization, tender access, surgeon training, installed equipment and after-sales support create meaningful entry barriers.

Market Share Distribution

Johnson & Johnson MedTech
Medtronic plc
B. Braun Melsungen AG
Olympus Corporation

Top 5 Players

1
Johnson & Johnson MedTech
!$*
2
Medtronic plc
^&
3
B. Braun Melsungen AG
#@
4
Olympus Corporation
$
5
Stryker Corporation
&@$
Combined Share$%

Market Dynamics

Local Players70%
Regional/Int'l30%

8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.

Company Profiles (Top 10 Players)
Company Name
Market Share
Headquarters
Founding Year
Core Market Focus
Johnson & Johnson MedTech
-New Brunswick, United States1886Ethicon stapling, energy, sutures, wound closure and surgical access
Medtronic plc
-Dublin, Ireland1949Advanced energy, stapling, electrosurgery and minimally invasive surgery
B. Braun Melsungen AG
-Melsungen, Germany1839Aesculap instruments, laparoscopy, sutures, clips and energy devices
Olympus Corporation
-Tokyo, Japan1919Endoscopy, laparoscopy, visualization and surgical energy systems
Stryker Corporation
-Kalamazoo, United States1941Surgical visualization, insufflation, smoke evacuation and operating-room technology
Boston Scientific Corporation
-Marlborough, United States1979Endoscopic and gastrointestinal intervention devices supporting surgical pathways
CONMED Corporation
-Largo, United States1970Electrosurgery, laparoscopy, insufflation, smoke management and surgical instruments
KARL STORZ SE & Co. KG
-Tuttlingen, Germany1945Endoscopic visualization, laparoscopic instruments and integrated operating rooms
Teleflex Incorporated
-Wayne, United States1943Surgical ligation, access, retraction and specialty procedure devices
Smith+Nephew plc
-Watford, United Kingdom1856Advanced wound management, visualization and selected surgical technologies

Cross Comparison Parameters

The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.

Analysis Covered

Market Share Analysis:

Compares supplier positions across products, hospitals, procedures and geographic clusters

Cross Comparison Matrix:

Benchmarks commercial scale, clinical access, service capability and financial performance

SWOT Analysis:

Evaluates portfolio strengths, operational vulnerabilities, opportunities and competitive exposure factors

Pricing Strategy Analysis:

Assesses tender pricing, distributor margins, consumable economics and bundled contracts

Company Profiles:

Reviews ownership, portfolio focus, market presence and strategic positioning

CHAPTER 10 - REPORT TOC

Table of Contents

99Pages
34Chapters
10Companies Profiled
7Segmentation Types

Phase 1
Market Assessment Phase

11

Chapters

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

Phase 2
Go-To-Market Strategy Phase

15

Chapters

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

Complete Report Coverage

201+ detailed sections covering every aspect of the market

143

Assessment Sections

58

Strategy Sections

CHAPTER 11 - Our Approach

Research Methodology

Desk Research

  • Review surgical device registrations
  • Analyze hospital procedure capacity
  • Map imported device portfolios
  • Examine tender pricing disclosures

Primary Research

  • Interview general surgery department heads
  • Consult hospital procurement directors
  • Engage medical device distributors
  • Interview operating-room managers

Validation and Triangulation

  • Validate estimates across 320 respondents
  • Reconcile procedure and revenue data
  • Cross-check tender and distributor volumes
  • Test ASP and utilization assumptions

CHAPTER 12 - FAQ

FAQs

Still have questions?

Our research team is here to help you find the right solution

Contact Research Team

CHAPTER 13 - Related Research

Explore Related Reports

Expand your market intelligence with complementary research across regions and adjacent markets.

Regional/Country Reports

Related market analysis across key regions

Adjacent Reports

Related markets and complementary research

500+

Market Research Reports

50+

Countries Covered

15+

Industry Verticals

Want the full report and an analyst walkthrough?

Unlock the complete dataset, segmentation cuts, and competitive analysis—plus a discovery call that maps insights to your go-to-market priorities.

;